Aim: This presentation will provide an overview of the components of obesity interventions that improve the maintenance of lost weight. Methods: Over the past two decades, an array of treatment strategies have been designed to improve long-term outcome, including the use of pharmacotherapy, very-lowcalorie diets, extended care, skills training, monetary incentives, meal substitutes, social support, exercise/physical activity, and multi-component regimens. This presentation will provide a selective review of studies that have examined the effectiveness of these approaches. Results: Very-low calorie diets, skills training without followup care, peer group meetings, telephone contacts by nontherapists, supervised group exercise, and monetary incentives generally have not improved long-term outcome. However, extending lifestyle treatments beyond six months and the use of multi-component regimens, particularly those that include pharamacotherapy, appear to enhance the maintenance of lost weight. Conclusions: Successful long-term management of obesity may require interventions that extend over long periods of time and include a multi-faceted approach to treatment. Aims: Since results with placebo often are positive, we compared the role of dietary restraint during weight-loss and weight-maintenance, with e.g. exercise or leptin treatment. Methods: For example, two studies conducted weight loss (through a very low energy diet), respectively weight maintenance programs in 29 men (BMI 32±0.4 kg/m 2 ; age 39±1.4 yrs), and in 24 men (BMI 29±0.3 kg/m 2 ; age 35±1), while dietary restraint (F1) and general hunger (F3) were determined using the Three Factor Eating Questionnaire (TFEQ) at the start and end of studies and after weight loss. Half of the 29 men also participated in an exercise program throughout the study, whereas half of the 24 men received 80 mg/week PEG-OB during the weight loss period. Results: These studies are examples of weight loss (15±1kg) as well as weight-maintenance thereafter being related to an increase in F1 during energy restriction (e.g. r 2 =0.6; p<0.01). This relationship is usually stronger in the placebo than in the treatment group, and appears to be a general phenomenon with treatments lacking differences in results from placebo. Conclusions: Increase in dietary restraint may cause the placebo effect during weight maintenance. It appears to be a successful tool used by subjects under placebo treatment during weight loss as well as during weight maintenance.
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